Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study

Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study

Abstract Background Basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) are benign and malignant, basaloid salivary gland neoplasms, respectively. These tumors show a dual-cell proliferation of inner luminal/ductal cells and outer abluminal/myoepithelial or basal cells. The only difference...

Full description

Bibliographic Details
Main Authors: Yuzo Oyama, Haruto Nishida, Takahiro Kusaba, Hiroko Kadowaki, Motoki Arakane, Junpei Wada, Shogo Urabe, Takashi Hirano, Kenji Kawano, Masashi Suzuki, Shigeo Yokoyama, Tsutomu Daa
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Diagnostic Pathology
Subjects:
TLE1
Basal cell adenoma
Basal cell adenocarcinoma
β-catenin
Online Access:http://link.springer.com/article/10.1186/s13000-018-0726-8

Internet

http://link.springer.com/article/10.1186/s13000-018-0726-8

Similar Items